Literature DB >> 2851418

Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription.

K M Rose1, J Szopa, F S Han, Y C Cheng, A Richter, U Scheer.   

Abstract

RNA polymerase I preparations purified from a rat hepatoma contained DNA topoisomerase activity. The DNA topoisomerase associated with the polymerase had an Mr of 110,000, required Mg2+ but not ATP, and was recognized by anti-topoisomerase I antibodies. When added to RNA polymerase I preparations containing topoisomerase activity, anti-topoisomerase I antibodies were able to inhibit the DNA relaxing activity of the preparation as well as RNA synthesis in vitro. RNA polymerase II prepared by analogous procedures did not contain topoisomerase activity and was not recognized by the antibodies. The topoisomerase I: polymerase I complex was reversibly dissociated by column chromatography on Sephacryl S200 in the presence of 0.25 M (NH4)2SO4. Topoisomerase I was immunolocalized in the transcriptionally active ribosomal gene complex containing RNA polymerase I in situ. These data indicate that topoisomerase I and RNA polymerase I are tightly complexed both in vivo and in vitro, and suggest a role for DNA topoisomerase I in the transcription of ribosomal genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851418     DOI: 10.1007/bf00303034

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  38 in total

1.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

Authors:  H Zhang; J C Wang; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination.

Authors:  P Bullock; J J Champoux; M Botchan
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

3.  5S RNA gene specific transcription factor (TFIIIA) changes the linking number of the DNA.

Authors:  B S Shastry
Journal:  Biochem Biophys Res Commun       Date:  1986-02-13       Impact factor: 3.575

4.  An activity from mammalian cells that untwists superhelical DNA--a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay).

Authors:  J J Champoux; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Properties of active nucleosomes as revealed by HMG 14 and 17 chromatography.

Authors:  S T Weisbrod
Journal:  Nucleic Acids Res       Date:  1982-03-25       Impact factor: 16.971

7.  Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.

Authors:  L C Garg; S DiAngelo; S T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  A heparin-sensitive nuclear protein kinase. Purification, properties, and increased activity in rat hepatoma relative to liver.

Authors:  K M Rose; L E Bell; D A Siefken; S T Jacob
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

9.  RNA polymerase I in hepatoma 3924A: mechanism of enhanced activity relative to liver.

Authors:  K M Rose; B W Duceman; D Stetler; S T Jacob
Journal:  Adv Enzyme Regul       Date:  1983

10.  Mutations in the gene coding for Escherichia coli DNA topoisomerase I affect transcription and transposition.

Authors:  R Sternglanz; S DiNardo; K A Voelkel; Y Nishimura; Y Hirota; K Becherer; L Zumstein; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  33 in total

1.  Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones.

Authors:  J J Champoux
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

2.  Is higher-order structure conserved in eukaryotic ribosomal DNA intergenic spacers?

Authors:  G D Baldridge; M W Dalton; A M Fallon
Journal:  J Mol Evol       Date:  1992-12       Impact factor: 2.395

3.  Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature.

Authors:  S Krogh; U H Mortensen; O Westergaard; B J Bonven
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

Review 4.  Nucleolar adaptation in human cancer.

Authors:  Leonard B Maggi; Jason D Weber
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

5.  Evolution of repeated sequences in the ribosomal DNA intergenic spacer of 32 arthropod species.

Authors:  Cheryl D Ambrose; Teresa J Crease
Journal:  J Mol Evol       Date:  2010-02-27       Impact factor: 2.395

Review 6.  Multiparameter microscopic analysis of nucleolar structure and ribosomal gene transcription.

Authors:  M F Trendelenburg; O V Zatsepina; T Waschek; W Schlegel; H Tröster; D Rudolph; G Schmahl; H Spring
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

7.  Localization of the active type I DNA topoisomerase gene on human chromosome 20q11.2-13.1, and two pseudogenes on chromosomes 1q23-24 and 22q11.2-13.1.

Authors:  N Kunze; G C Yang; Z Y Jiang; H Hameister; S Adolph; K H Wiedorn; A Richter; R Knippers
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

8.  Human topoisomerase 1 messenger RNA is not destabilized by the herpes simplex virus type 2 virion-associated shut-off function.

Authors:  K F Bastow; B S Zhou; Y C Cheng
Journal:  Virus Genes       Date:  1989-08       Impact factor: 2.332

9.  Binding of sequences from the 5'- and 3'-nontranscribed spacers of the rat rDNA locus to the nucleolar matrix.

Authors:  E Stephanova; R Stancheva; Z Avramova
Journal:  Chromosoma       Date:  1993-03       Impact factor: 4.316

10.  FACT facilitates chromatin transcription by RNA polymerases I and III.

Authors:  Joanna L Birch; Bertrand C-M Tan; Kostya I Panov; Tatiana B Panova; Jens S Andersen; Tom A Owen-Hughes; Jackie Russell; Sheng-Chung Lee; Joost C B M Zomerdijk
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.